FREENOME
Freenome is a biotech company developing accurate, accessible, and non-invasive disease screening products for proactively treating cancer and other diseases at their most manageable stages. The company is developing a simple blood test to detect early-stage cancer and make treatments more effective and provides a platform that helps design healthy conditions for an individual based on his/her cell-free genome. The company aims to reinvent disease management through systematized early detection and intervention. Charles Roberts, Gabriel Otte, Riley Ennis, and Michael Otte launched the company in 2014 in South San Francisco, California.
FREENOME
Industry:
Biotechnology Health Care Health Diagnostics Personal Health
Founded:
2014-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.freenome.com
Total Employee:
251+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
1.1 B USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Google Tag Manager Content Delivery Network Google Universal Analytics Font Awesome Domain Not Resolving
Similar Organizations
BioFluidica
BioFluidica is a biotechnology company that has developed a diagnostic platform.
Lucira Health
Lucira Health is a biotechnology company that offers disposable test kits to detect RNA and DNA of infectious diseases.
Human Longevity
Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.
ORIG3N
ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.
Vera Therapeutics
Vera Therapeutics is a biotechnology company developing innovative biologic therapeutics with transformative clinical potential.
Current Advisors List
Current Employees Featured
Founder
Investors List
Roche
Roche investment in Corporate Round - Freenome
Polaris Partners
Polaris Partners investment in Series D - Freenome
Pura Vida Investments
Pura Vida Investments investment in Series D - Freenome
Kaiser Permanente
Kaiser Permanente investment in Series D - Freenome
Andreessen Horowitz
Andreessen Horowitz investment in Series D - Freenome
RA Capital Management
RA Capital Management investment in Series D - Freenome
Artis Ventures (AV)
Artis Ventures (AV) investment in Series D - Freenome
Eventide
Eventide investment in Series D - Freenome
Bain Capital Life Sciences
Bain Capital Life Sciences investment in Series D - Freenome
Logos Capital
Logos Capital investment in Series D - Freenome
Newest Events participated
Official Site Inspections
http://www.freenome.com Semrush global rank: 1.19 M Semrush visits lastest month: 25.91 K
- Host name: 23.185.0.2
- IP address: 23.185.0.2
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Freenome"
Our Company | Learn About Freenome's Team
Freenome is led by an experienced management team and backed by exemplary institutional and strategic investors with substantial oncology, diagnostics, and operational expertise.See details»
Freenome - Crunchbase Company Profile & Funding
Freenome is a biotech company developing accurate, accessible, and non-invasive disease screening products for proactively treating cancer and other diseases at their most manageable stages. The company is developing a …See details»
Freenome - LinkedIn
Freenome | 33,718 followers on LinkedIn. Outpacing cancer starts with early detection | Freenome is a high-growth biotech company on a mission since 2014 to create tools that empower everyone to ...See details»
Freenome Company Profile 2024: Valuation, Funding
Freenome General Information Description. Developer of a multi-omics platform designed to detect cancer at an early stage through a routine blood draw. The company's platform uses a proprietary algorithm method that aims to reinvent …See details»
Freenome Announces CEO Transition - Freenome
Sep 25, 2024 SOUTH SAN FRANCISCO, CA (September 25, 2024) — Freenome today announced that Mike Nolan has resigned from his position as chief executive officer (CEO) for …See details»
Freenome Company Profile - Office Locations, Competitors ... - Craft
Freenome has 5 employees at their 1 location and $507.55 m in total funding,. See insights on Freenome including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
Freenome Raises $254 Million in New Funding to Accelerate its …
Feb 15, 2024 Freenome, a biotechnology company developing blood tests for early cancer detection, announced the addition of $254 million from new and existing investors. The funding …See details»
Freenome Announces CEO Transition - Morningstar
Sep 25, 2024 The board will be selecting a successor to guide the organization toward commercialization and increasing its public presence as Freenome focuses on bringing blood …See details»
Freenome Raises $254 Million in New Funding to …
Feb 15, 2024 Freenome is leveraging its multiomics platform, which uses computational biology, machine learning and other technologies to develop screening tools to detect cancer in its earliest, most ...See details»
Freenome - GitHub
Freenome is a high-growth biotech company developing next-generation blood tests to detect cancer in its earliest, most treatable stages. - Freenome ... We've verified that the organization freenome controls the domain: …See details»
Freenome - Funding, Financials, Valuation & Investors - Crunchbase
Freenome is funded by 54 investors. BrightEdge Fund and T. Rowe Price are the most recent investors. Freenome has a post-money valuation in the range of $1B to $10B as of Feb 15, …See details»
Freenome Raises $254 Million in New Funding to Accelerate its
Feb 15, 2024 Freenome is leveraging its multiomics platform, which uses computational biology, machine learning and other technologies to develop screening tools to detect cancer in its …See details»
Significant Investment Accelerates Freenome’s Multiomics …
Jan 11, 2022 SOUTH SAN FRANCISCO, January 11, 2022 — Freenome, a privately held biotech company, announced today that Roche has made an investment of $290 million, …See details»
Freenome - Contacts, Employees, Board Members, Advisors
Organization. Freenome . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. ... Freenome has 13 current employee …See details»
Freenome Raises $254M for Multiomic-Based Early Cancer Detection
Feb 16, 2024 Freenome has announced $254M of new funding, led by Roche but with multiple other firms participating, to advance the company’s pipeline of single- and multiple-cancer …See details»
Freenome Closes $270 Million Series C Financing to Advance …
Aug 26, 2020 Freenome CEO Gabriel Otte stated, “We are delighted to have Bain Capital Life Sciences and Perceptive Advisors as lead investors, and thank all of our new and existing …See details»
Freenome Raises $254 Million in New Funding to Accelerate its …
Feb 15, 2024 The study is intended to validate Freenome’s lung screening test in current and former smokers 50 years and older who are eligible for screening with an LDCT scan. …See details»
Newsroom - Freenome
May 22, 2023 Freenome presented modeling findings at ASCO that demonstrate favorable outcomes in a Medicare-aged cohort SOUTH SAN FRANCISCO, June 7, 2021 — Freenome, …See details»